<DOC>
	<DOCNO>NCT00808405</DOCNO>
	<brief_summary>To examine time heal genital lesion duration herpes simplex virus ( HSV ) shed genetic ulcer disease ( GUD ) among 90 HIV-negative African woman history GUD HSV-2 seropositive HIV-1 seronegative randomize 2:1 ratio receive episodic acyclovir 400mg orally three time daily match placebo three time daily 5 day follow total 13 day .</brief_summary>
	<brief_title>GUD Clinical Virologic Response Acyclovir HIV Negative African Women</brief_title>
	<detailed_description />
	<mesh_term>Herpes Genitalis</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>HIV negative determine concordant rapid test HSV2 seropositive ( Focus HerpeSelect &gt; 3.4 ) At least one prior occurrence GUD 1850 year age Current use , use w/in past 7 day acyclovir , valacyclovir , famciclovir Prior hypersensitivity &amp; /or allergic reaction acyclovir Use probenicid Current use , use within past 28 day , investigational agent Currently pregnant nursing Currently plan become pregnant next 3 month Any condition interfere successful completion study procedure</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>herpes simplex virus</keyword>
	<keyword>acyclovir</keyword>
	<keyword>HSV shed</keyword>
	<keyword>woman</keyword>
	<keyword>Africa</keyword>
</DOC>